Identifying Dysregulated Epigenetic Enzyme Activity in Castrate-Resistant Prostate Cancer Development.

MLA

Lee, Jin-Hee, et al. “Identifying Dysregulated Epigenetic Enzyme Activity in Castrate-Resistant Prostate Cancer Development.” ACS Chemical Biology, vol. 12, no. 11, Nov. 2017, pp. 2804–14. EBSCOhost, https://doi.org/10.1021/acschembio.6b01035.

APA

Lee, J.-H., Yang, B., Lindahl, A. J., Damaschke, N., Boersma, M. D., Huang, W., Corey, E., Jarrard, D. F., & Denu, J. M. (2017). Identifying Dysregulated Epigenetic Enzyme Activity in Castrate-Resistant Prostate Cancer Development. ACS Chemical Biology, 12(11), 2804–2814. https://doi.org/10.1021/acschembio.6b01035

Chicago

Lee, Jin-Hee, Bing Yang, Anastasia J Lindahl, Nathan Damaschke, Melissa D Boersma, Wei Huang, Eva Corey, David F Jarrard, and John M Denu. 2017. “Identifying Dysregulated Epigenetic Enzyme Activity in Castrate-Resistant Prostate Cancer Development.” ACS Chemical Biology 12 (11): 2804–14. doi:10.1021/acschembio.6b01035.